Avid Bioservices Inc (CDMO) - News Archive

Avid Bioservices Acquired by GHO Capital and Ampersand Capital Partners: Charting a Promising Path in Biologics ManufacturingIn an era where biotechnology continues to shape the future of medicine, Avid Bioservices, a p...

Avid Bioservices Poised for Significant Growth with New Partners GHO Capital and Ampersand Capital PartnersIntroductionIn a major development for the biotechnology and pharmaceutical landscape, GHO Capital Partners LLP,...

On January 30, 2025, Avid Bioservices, Inc. (NASDAQ: CDMO) took a significant step towards enhancing its position in the biologics contract development and manufacturing sector. During a special meeting, stockholders ov...

In an unfolding narrative that continues to capture the attention of the investment community, Avid Bioservices has taken decisive steps to communicate the tangible benefits of its recent strategic partnerships. In a le...

Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and Vote FOR the Transaction with GHO and AmpersandIn a recent comprehensive press release, Avid Bioservices Inc. has strongly urged its stockho...

Avid Urges Stockholders to Vote FOR the Pending Transaction TODAYIn a decisive move within the biopharmaceutical sector, Avid Bioservices Inc. (NASDAQ: CDMO) is urging its stockholders to vote in favor of the upcoming a...

On December 30, 2024, Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated contract development and manufacturing organization (CDMO) specializing in biologics, heralded an important milestone in its proposed acquisition...

Avid Bioservices Advocates for Shareholder Approval of Value Maximizing Transaction: What It Means for InvestorsIn a recent development, Avid Bioservices Inc. (NASDAQ: CDMO) has taken a significant step towards enhancin...

IntroductionIn a significant move that could reshape the landscape of biologics contract development and manufacturing, Avid Bioservices, Inc. (NASDAQ: CDMO) has agreed to be acquired by GHO Capital Partners and Ampersa...

Investing in the stock market can be highly rewarding, but it also carries a certain degree of risk. As shareholders, we place our trust in companies and their management to make sound decisions that will benefit us. Ho...

Avid Bioservices Faces Nasdaq Notice for Late Filing, As Stock Performs Below Expectations TUSTIN, Calif., March 20, 2024 - Avid Bioservices, Inc. (Nasdaq: CDMO), a renowned biologics contract development and manufactur...

Avid Bioservices, Inc. (NASDAQ:CDMO), a renowned biologics contract development and manufacturing organization (CDMO), revealed the successful pricing of $160 million aggregate principal amount of 7.00% Convertible Seni...

Convertible Senior Notes Offering by Avid Bioservices Inc. to Impact Shareholders and Financial MarketIn a recent press release, Avid Bioservices Inc. (NASDAQ:CDMO) has revealed its plans to offer $160 million aggregate...